International trade · 05/05/2022

U.S. International Trade Commission to Investigate Botulinum Toxin Products from South Korea

The U.S. International Trade Commission has been asked to investigate allegations that Medytox Inc., a South Korean company, is violating U.S. trade laws by importing and selling botulinum toxin products that were stolen or misappropriated from American companies, posing a threat to the U.S. industry.